1. Home
  2. VTRS vs BSAC Comparison

VTRS vs BSAC Comparison

Compare VTRS & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • BSAC
  • Stock Information
  • Founded
  • VTRS 1961
  • BSAC 1977
  • Country
  • VTRS United States
  • BSAC Chile
  • Employees
  • VTRS N/A
  • BSAC N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • BSAC Commercial Banks
  • Sector
  • VTRS Health Care
  • BSAC Finance
  • Exchange
  • VTRS Nasdaq
  • BSAC Nasdaq
  • Market Cap
  • VTRS 12.2B
  • BSAC 13.4B
  • IPO Year
  • VTRS N/A
  • BSAC 1994
  • Fundamental
  • Price
  • VTRS $11.00
  • BSAC $30.51
  • Analyst Decision
  • VTRS Hold
  • BSAC Hold
  • Analyst Count
  • VTRS 6
  • BSAC 3
  • Target Price
  • VTRS $11.17
  • BSAC $26.67
  • AVG Volume (30 Days)
  • VTRS 9.0M
  • BSAC 286.0K
  • Earning Date
  • VTRS 11-06-2025
  • BSAC 10-30-2025
  • Dividend Yield
  • VTRS 4.29%
  • BSAC 3.28%
  • EPS Growth
  • VTRS N/A
  • BSAC 42.15
  • EPS
  • VTRS N/A
  • BSAC 0.01
  • Revenue
  • VTRS $14,124,400,000.00
  • BSAC $2,434,135,287.00
  • Revenue This Year
  • VTRS N/A
  • BSAC $41.31
  • Revenue Next Year
  • VTRS $1.61
  • BSAC $5.39
  • P/E Ratio
  • VTRS N/A
  • BSAC $12.55
  • Revenue Growth
  • VTRS N/A
  • BSAC 20.98
  • 52 Week Low
  • VTRS $6.85
  • BSAC $18.19
  • 52 Week High
  • VTRS $13.55
  • BSAC $30.22
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 63.94
  • BSAC 79.01
  • Support Level
  • VTRS $9.92
  • BSAC $28.27
  • Resistance Level
  • VTRS $11.28
  • BSAC $30.18
  • Average True Range (ATR)
  • VTRS 0.34
  • BSAC 0.60
  • MACD
  • VTRS 0.05
  • BSAC 0.12
  • Stochastic Oscillator
  • VTRS 80.51
  • BSAC 90.85

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.

Share on Social Networks: